Required regulatory filings regarding institutional holdings were made by Gilead Sciences, Inc. with the Securities and Exchange Commission on June 11, 2026.
4 reports, 2 independent
Updated Jun 18
Gone quiet
- Reports
- 4
- Developments
- 3
- Repetition
- 25%
New informationRepeats or wire copies
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
Required regulatory filings regarding institutional holdings were made by Gilead Sciences, Inc. with the Securities and Exchange Commission on June 11, 2026.
Who's involved
What this event is mainly aboutHow it developed
Newest first. Tap a step to see who reported it.Gilead Sciences disclosed transactions with the SEC.1 source
Gilead Sciences filed reports with the SEC.1 source
Gilead Sciences made required institutional holdings filings with the SEC.1 source
Keep exploring
The entities involved
-
Securities and Exchange Commission
government agency of the Philippines
-
Gilead Sciences
American company
-
SEC
Slovak company
Related events
- Filings made with the SEC regarding stock holdings by Warner Bros. Discovery.
- Corcept Therapeutics made required filings with the SEC regarding institutional holdings on June 16, 2026.
- Regeneron Pharmaceuticals filed required reports with the SEC regarding institutional holdings on September 8, 2026.
- Gilead Sciences acquired Arcellx and presented priorities at a Wells Fargo conference, while also discussing submissions with the FDA and CDC.
- General Dynamics filed with the SEC on June 6, 2026, regarding required institutional holdings disclosures.